메뉴 건너뛰기




Volumn 7, Issue 6, 2006, Pages 462-467

Antimuscarinic therapy in men with lower urinary tract symptoms: What is the evidence?

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN; TOLTERODINE;

EID: 33750505005     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-006-0055-4     Document Type: Article
Times cited : (11)

References (21)
  • 1
    • 0032032069 scopus 로고    scopus 로고
    • Health related quality of life associated with lower urinary tract symptoms in four countries
    • Girman CJ, Jacobsen SJ, Tsukamoto T, et al.: Health related quality of life associated with lower urinary tract symptoms in four countries. Urology 1998, 51:428-433.
    • (1998) Urology , vol.51 , pp. 428-433
    • Girman, C.J.1    Jacobsen, S.J.2    Tsukamoto, T.3
  • 2
    • 0031023064 scopus 로고    scopus 로고
    • The International Continence Society Benign Prostatic Hyperplasia Study: The bothersomeness of urinary symptoms
    • Peters TJ, Donovan JL, Kay HE, et al.: The International Continence Society Benign Prostatic Hyperplasia Study: the bothersomeness of urinary symptoms. J Urol 1997, 157:885.
    • (1997) J Urol , vol.157 , pp. 885
    • Peters, T.J.1    Donovan, J.L.2    Kay, H.E.3
  • 3
    • 0035027148 scopus 로고    scopus 로고
    • BOO with coexisting overactive bladder dysfunction-an everyday urological dilemma
    • Knutson T, Edlund C, Fall M, Dahlstrand C: BOO with coexisting overactive bladder dysfunction-an everyday urological dilemma. Neurourol Urodyn 2001, 20:237-247.
    • (2001) Neurourol Urodyn , vol.20 , pp. 237-247
    • Knutson, T.1    Edlund, C.2    Fall, M.3    Dahlstrand, C.4
  • 4
    • 11144221994 scopus 로고    scopus 로고
    • Serum prostate specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms
    • Laniado ME, Ockrim JL, Marronaro A, et al.: Serum prostate specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 2004, 94:1283-1286.
    • (2004) BJU Int , vol.94 , pp. 1283-1286
    • Laniado, M.E.1    Ockrim, J.L.2    Marronaro, A.3
  • 5
    • 0035664491 scopus 로고    scopus 로고
    • Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia
    • Eckhardt MD, van Verooij GE, Boon TA: Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia. Urology 2001, 58:966-971.
    • (2001) Urology , vol.58 , pp. 966-971
    • Eckhardt, M.D.1    Van Verooij, G.E.2    Boon, T.A.3
  • 6
    • 8144221209 scopus 로고    scopus 로고
    • Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder
    • Lee JY, Kim HW, Lee SJ, et al.: Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004, 94:817. A sequential therapy trial using combination therapy in men initially stabilized on α-blockers.
    • (2004) BJU Int , vol.94 , pp. 817
    • Lee, J.Y.1    Kim, H.W.2    Lee, S.J.3
  • 7
    • 4544266557 scopus 로고    scopus 로고
    • Pharmacologic therapy of benign prostatic hyperplasia/ lower urinary tract symptoms: An overview for the practicing clinician
    • Chapple CR: Pharmacologic therapy of benign prostatic hyperplasia/ lower urinary tract symptoms: an overview for the practicing clinician. BJU Int 2004, 94:738.
    • (2004) BJU Int , vol.94 , pp. 738
    • Chapple, C.R.1
  • 8
    • 0034934163 scopus 로고    scopus 로고
    • Detrusor instability in men; correlation of lower urinary tract symptoms with urodynamic findings
    • Hyman MJ, Groutz A, Blaivas JG: Detrusor instability in men; correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001, 166:550.
    • (2001) J Urol , vol.166 , pp. 550
    • Hyman, M.J.1    Groutz, A.2    Blaivas, J.G.3
  • 9
    • 0035693995 scopus 로고    scopus 로고
    • Can urodynamic assessment of outflow obstruction predict outcome from watchful waiting? - A four year follow-up study
    • Knutson T, Schafer W, Fall M, et al.: Can urodynamic assessment of outflow obstruction predict outcome from watchful waiting? - A four year follow-up study. Scand J Urol Nephrol 2001, 35:463.
    • (2001) Scand J Urol Nephrol , vol.35 , pp. 463
    • Knutson, T.1    Schafer, W.2    Fall, M.3
  • 10
    • 0344431427 scopus 로고    scopus 로고
    • Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns
    • abstract 1048
    • Abrams P: Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns [abstract 1048]. J Urol 2002, 167(Suppl):266.
    • (2002) J Urol , vol.167 , Issue.SUPPL. , pp. 266
    • Abrams, P.1
  • 11
    • 32044449411 scopus 로고    scopus 로고
    • Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
    • Abrams P, Kaplan S, De Koning Gans HJ, Millard R: Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006, 175:999-1004. This is a very well-documented trial using thorough urodynamic evaluation to completely characterize outlet obstruction in treated men.
    • (2006) J Urol , vol.175 , pp. 999-1004
    • Abrams, P.1    Kaplan, S.2    De Koning Gans, H.J.3    Millard, R.4
  • 12
    • 0032768638 scopus 로고    scopus 로고
    • Bladder outlet obstruction index, bladder contractility index, and bladder voiding efficiency: Three simple indices to define bladder voiding function
    • Abrams P: Bladder outlet obstruction index, bladder contractility index, and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999, 84:14.
    • (1999) BJU Int , vol.84 , pp. 14
    • Abrams, P.1
  • 13
    • 0038286511 scopus 로고    scopus 로고
    • Combination treatment with an alpha blocker plus an anticholinergic for bladder outlet obstruction: A prospective, randomized, controlled study
    • Athanasopoulos A, Gyftopoulos K, Giannitsas K, et al.: Combination treatment with an alpha blocker plus an anticholinergic for bladder outlet obstruction: A prospective, randomized, controlled study. J Urol 2003, 169:2253-2256. This is a combination study with patients well-characterized with urodynamics. Also, it is a reasonable assessment of adverse event outcomes.
    • (2003) J Urol , vol.169 , pp. 2253-2256
    • Athanasopoulos, A.1    Gyftopoulos, K.2    Giannitsas, K.3
  • 14
    • 0031397010 scopus 로고    scopus 로고
    • Construction and validation of a short- Form benign prostatic hypertrophy health related quality of life questionnaire
    • BPH group in general practice
    • Lukacs B, Comet D, Grange JC, Thibault P: Construction and validation of a short- form benign prostatic hypertrophy health related quality of life questionnaire. BPH group in general practice. Br J Urol 1997, 80:722.
    • (1997) Br J Urol , vol.80 , pp. 722
    • Lukacs, B.1    Comet, D.2    Grange, J.C.3    Thibault, P.4
  • 15
    • 3042755102 scopus 로고    scopus 로고
    • A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence
    • Saito H, Yamada T, Oshima H, et al.: A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence. Jpn J Urol Surg 1999, 12:525-536.
    • (1999) Jpn J Urol Surg , vol.12 , pp. 525-536
    • Saito, H.1    Yamada, T.2    Oshima, H.3
  • 16
    • 24944527452 scopus 로고    scopus 로고
    • Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointerstinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: A prospective, randomized, controlled multicenter study
    • Lee K-S, Choo M-S, Kim D-Y, et al.: Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointerstinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study. J Urol 2005, 174:1334-1338. This is a study that uses sequential addition of antimuscarinic medication in men who failed initial therapy with α-blockade but showed substantial improvement in symptoms with combined therapy.
    • (2005) J Urol , vol.174 , pp. 1334-1338
    • Lee, K.-S.1    Choo, M.-S.2    Kim, D.-Y.3
  • 17
    • 27744523690 scopus 로고    scopus 로고
    • Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia
    • Kaplan SJ, Walmsley K, Te A: Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005, 174:2273-2276. The only study to date of antimuscarinic treatment in men who have failed prior therapy for LUTS.
    • (2005) J Urol , vol.174 , pp. 2273-2276
    • Kaplan, S.J.1    Walmsley, K.2    Te, A.3
  • 18
    • 34848824466 scopus 로고    scopus 로고
    • Effects of tamsulosin and extended release oxybutynin on lower urinary tract symptoms in men
    • abstract 1639
    • Macdiarmid S, Chen A, Tu N, et al.: Effects of tamsulosin and extended release oxybutynin on lower urinary tract symptoms in men [abstract 1639]. J Urol 2006, 175:528. A combination study using initial therapy with both classes of medications rather than sequential addition.
    • (2006) J Urol , vol.175 , pp. 528
    • Macdiarmid, S.1    Chen, A.2    Tu, N.3
  • 20
    • 33644872094 scopus 로고    scopus 로고
    • A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder
    • Chapple CR, Roehrborn CG: A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006, 49:651-659. A review commentary on the evolving understanding of male LUTS, including review of apropos use of nomenclature and role of urodynamic evaluation in patients with mixed symptoms.
    • (2006) Eur Urol , vol.49 , pp. 651-659
    • Chapple, C.R.1    Roehrborn, C.G.2
  • 21
    • 33748335370 scopus 로고    scopus 로고
    • Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systemic review
    • In press
    • Novara G, Galfano A, Ficarra V, Artibani W: Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systemic review. Eur Urol 2006, In press.
    • (2006) Eur Urol
    • Novara, G.1    Galfano, A.2    Ficarra, V.3    Artibani, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.